Most insights into the molecular mechanisms underlying ERα signalling stem from in vitro studies with ERα-positive (ERα+) breast cancer cell lines, in particular MCF-7 cells which express very high levels of the receptor and are exquisitely sensitive to E2. This evidence concerns the gene ESR1 and breast carcinoma.